Literature DB >> 14752869

Cefepime vs. Meropenem as empirical therapy for neutropenic fever in children with lymphoma and solid tumours.

Tezer Kutluk1, Ogün Kurne, Canan Akyüz, Mehmet Ceyhan, Güler Kanra, Münevver Büyükpamukçu, Gülten Seçmeer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14752869     DOI: 10.1002/pbc.10442

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


× No keyword cloud information.
  8 in total

Review 1.  Outpatient and oral antibiotic management of low-risk febrile neutropenia are effective in children--a systematic review of prospective trials.

Authors:  A Manji; J Beyene; L L Dupuis; R Phillips; T Lehrnbecher; L Sung
Journal:  Support Care Cancer       Date:  2012-03-09       Impact factor: 3.603

Review 2.  A systematic review and meta-analysis of anti-pseudomonal penicillins and carbapenems in pediatric febrile neutropenia.

Authors:  Arif Manji; Thomas Lehrnbecher; L Lee Dupuis; Joseph Beyene; Lillian Sung
Journal:  Support Care Cancer       Date:  2011-12-06       Impact factor: 3.603

Review 3.  Meropenem: a review of its use in the treatment of serious bacterial infections.

Authors:  Claudine M Baldwin; Katherine A Lyseng-Williamson; Susan J Keam
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 4.  Anti-pseudomonal beta-lactams for the initial, empirical, treatment of febrile neutropenia: comparison of beta-lactams.

Authors:  Mical Paul; Dafna Yahav; Assaf Bivas; Abigail Fraser; Leonard Leibovici
Journal:  Cochrane Database Syst Rev       Date:  2010-11-10

5.  Cefepime Efficacy and Safety in Children: A Systematic Review and Meta-analysis.

Authors:  Saber Jan; Braveen Ragunanthan; Sandra R DiBrito; Omolabake Alabi; Maria Gutierrez
Journal:  Front Pediatr       Date:  2018-03-06       Impact factor: 3.418

6.  Comparative efficacy and safety of antipseudomonal β-lactams for pediatric febrile neutropenia: A systematic review and Bayesian network meta-analysis.

Authors:  Xinmei Tan; Yan Li; Jiaxi Xi; Sitong Guo; Henghai Su; Xiaoyu Chen; Xueyan Liang
Journal:  Medicine (Baltimore)       Date:  2021-12-17       Impact factor: 1.817

7.  Efficacy and Safety of Sitafloxacin in Treating Low-risk Febrile Neutropenia in Patients with Lung Cancer.

Authors:  Rintaro On; Takemasa Matsumoto; Noriyuki Ebi; Seiji Doi; Hiroshi Ishii; Makoto Furugen; Jiro Fujita; Maako Ide; Junji Kishimoto; Isamu Okamoto; Masaki Fujita
Journal:  JMA J       Date:  2022-05-23

8.  The Dose-Dependent Efficacy of Cefepime in the Empiric Management of Febrile Neutropenia: A Systematic Review and Meta-Analysis.

Authors:  Nikolaos Andreatos; Myrto Eleni Flokas; Anna Apostolopoulou; Michail Alevizakos; Eleftherios Mylonakis
Journal:  Open Forum Infect Dis       Date:  2017-05-24       Impact factor: 3.835

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.